Development of lentiviral vectors for gene therapy for human diseases
Open Access
- 15 April 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 95 (8) , 2499-2504
- https://doi.org/10.1182/blood.v95.8.2499
Abstract
Retroviral vectors derived from murine retroviruses are being used in several clinical gene therapy trials. Recently, progress has been made in the development of vectors based on the lentivirus genus of retroviruses, which ironically includes a major human pathogen, human immunodeficiency virus (HIV). As these vector systems for clinical gene transfer are developed, it is important to understand the rationale behind their design and development. This article reviews the fundamental features of retrovirus replication and of the elements necessary for development of a retroviral vector system, and it discusses why vector systems based on HIV or other lentiviruses have the potential to become important tools in clinical gene therapy.Keywords
This publication has 27 references indexed in Scilit:
- A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cellsNature, 2003
- HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integraseCell, 1995
- Transfer of Genes to Humans: Early Lessons and Obstacles to SuccessScience, 1995
- The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.Proceedings of the National Academy of Sciences, 1994
- Gene therapy for cancerTrends in Genetics, 1994
- Human gene therapy comes of ageNature, 1992
- Retrovirus Packaging CellsHuman Gene Therapy, 1990
- Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA.Proceedings of the National Academy of Sciences, 1990
- The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localizationCell, 1989
- Trans -Acting Transcriptional Regulation of Human T-Cell Leukemia Virus Type III Long Terminal RepeatScience, 1985